- NEWS FEATURE
Weight-loss-drug pioneer: this biochemist finally gained recognition for her work
Credit: Chris Taggart courtesy of The Rockefeller University
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
$1.95 to $39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 624, 506 (2023)
doi: https://doi.org/10.1038/d41586-023-03927-1
Obesity-drug pioneers win prestigious Lasker Award for medical science
After GLP-1, what’s next for weight loss?
Obesity-drug pioneers and 13,508 physicists win US$3-million Breakthrough Prizes
The weight-loss drugs being tested in 2025: will they beat Ozempic?
Experimental obesity drug packs double punch to reduce weight
Does Ozempic boost fertility? What the science says
Dozens of new obesity drugs are coming: these are the ones to watch
Daily briefing: No one knows how smell really works — scientists are sniffing out the answers
Anti-obesity drugs’ side effects: what we know so far
Obesity drugs have another superpower: taming inflammation
GLP-1 drugs fail to help some people lose weight — scientists are on a quest for answers
Game-changing obesity drugs go mainstream: what scientists are learning
Obesity drugs aren’t always forever. What happens when you quit?
